Prosecution Insights
Last updated: July 17, 2026
Application No. 18/947,003

Automated laser iridotomy

Non-Final OA §102§103
Filed
Nov 14, 2024
Priority
Mar 13, 2019 — provisional 62/817,587 +2 more
Examiner
CHRISTIANSON, SKYLAR LINDSEY
Art Unit
Tech Center
Assignee
BELKIN VISION LTD.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
1y 3m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
88 granted / 150 resolved
-1.3% vs TC avg
Strong +29% interview lift
Without
With
+28.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
32 currently pending
Career history
202
Total Applications
across all art units

Statute-Specific Performance

§101
3.6%
-36.4% vs TC avg
§103
78.3%
+38.3% vs TC avg
§102
6.3%
-33.7% vs TC avg
§112
3.1%
-36.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 150 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. 1. Claim(s) 1-3 and 6-8 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Guerrero (US 20080027519 A1). In regards to claims 1 and 6, Guerrero discloses a system/method, comprising: a laser (Par. 0047 teaches a laser), configured to: thin a target site in an iris of an eye by irradiating the target site with one or more first radiation-pulses (Par. 0057 teaches thinning the target tissue. Par. 0031 teaches this system is used to perform an iridotomy on the iris), and subsequently to thinning the target site, form a hole through the target site by irradiating the target site with one or more second radiation-pulses (Par. 0031 teaches that after thinning the iris, the laser can be used to create a hole in the iris); and a controller (Par. 0053 teaches a laser control system), configured to instruct the laser to increase a peak intensity of radiation beams emitted by the laser subsequently to the laser thinning the target site and prior to the laser forming the hole (Par. 0055 teaches the elements of the laser can be picked/controlled such as the laser power, i.e. intensity) In regards to claims 2 and 7, Guerrero discloses the system/method according to claim 1/6, wherein the controller is configured to increase the peak intensity by reducing a spot size of the radiation beams on the iris (Par. 0055-0056 teaches that there is a laser control system that can control the range of the laser power, i.e. intensity, as well as the laser spot size) In regards to claims 3 and 8, Guerrero discloses the system/method according to claim 1/6, wherein the controller is configured to increase the peak intensity by decreasing a pulse duration of the laser (Par. 0055 teaches that there is a laser control system that can control the range of the laser power, i.e. intensity, as well as the laser duration) Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. 2. Claim(s) 4-5 and 9-10 is/are rejected under 35 U.S.C. 103 as being unpatentable over Guerrero in view of Ogilvy (US 20090304033 A1). In regards to claims 4-5 and 9-10, Guerrero discloses the system/method according to claim 3/8, except for wherein the laser comprises an actively Q-switched laser comprising a Q-switch, and wherein the controller is configured to leave the Q-switch open for at least 100 ns for each of the first radiation-pulses, wherein the controller is further configured to pump the laser while the Q-switch is open for each of the first radiation-pulses.. However, in the same field of endeavor, Ogilvy discloses a laser system for treating the eyes (Abstract and Par. 0213) wherein a Q-switched laser is employed (Par. 0257) and wherein this Q-switch can be open for 1ns-150ns of the laser pulse (Par. 0257) in order to convert continuous laser light into a pulsed laser light (Par. 0204). Therefore, it would be obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have taken the teachings of Guerrero and modified them by having the laser be a Q-switched laser, as taught and suggested by Ogilvy, in order to convert continuous laser light into a pulsed laser light (Par. 0204 of Ogilvy). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SKYLAR LINDSEY CHRISTIANSON whose telephone number is (571)272-0533. The examiner can normally be reached Monday-Friday, 7:30-5:30 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /S.L.C./Examiner, Art Unit 3792 /LYNSEY C Eiseman/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Nov 14, 2024
Application Filed
Jun 09, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661068
A SYSTEM FOR DENOISING MOTION ARTIFACT SIGNALS AND METHOD THEREOF
4y 4m to grant Granted Jun 23, 2026
Patent 12661512
NEUROSTIMULATION USING ONE OR MORE CYCLING PARAMETERS FOR A NON-PARESTHESIA STIMULATION PATTERN
2y 2m to grant Granted Jun 23, 2026
Patent 12642699
SYSTEM AND METHOD FOR LASER TREATMENT OF OCULAR TISSUE USING NON-COLLINEAR IMAGING
3y 9m to grant Granted Jun 02, 2026
Patent 12539049
DEVICE FOR MONITORING BLOOD FLOW
2y 2m to grant Granted Feb 03, 2026
Patent 12527970
PHOTOBIOMODULATION DEVICE FOR TREATING RETINAL DISEASE
5y 7m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
88%
With Interview (+28.8%)
2y 11m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 150 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month